SEC Form 4 · accession 0001104659-26-080997
Silence Therapeutics plc · SLN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Ian Griffiths
10% Owner
Period of report
Jun 29, 2026
Accepted (ET)
Jul 7, 2026 · 9:09 am EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001479615
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| American Depositary SharesF1,F2 | $10.69 | Jun 29, 2026 | S | 330,072 | A | — | — | Ordinary Shares | 990,216 | 11,495,788 | I |
| American Depositary SharesF1,F2 | $10.76 | Jun 30, 2026 | S | 169,928 | A | — | — | Ordinary Shares | 509,784 | 11,325,860 | I |
| American Depositary SharesF1,F2 | $10.62 | Jul 1, 2026 | S | 79,180 | A | — | — | Ordinary Shares | 237,540 | 11,246,680 | I |
| American Depositary SharesF1,F2 | $10.62 | Jul 1, 2026 | S | 50,000 | A | — | — | Ordinary Shares | 150,000 | 11,196,680 | I |
| American Depositary SharesF1,F2 | $10.47 | Jul 2, 2026 | S | 50,082 | A | — | — | Ordinary Shares | 150,246 | 11,146,598 | I |
| American Depositary SharesF1,F2 | $10.53 | Jul 6, 2026 | S | 865,112 | A | — | — | Ordinary Shares | 2,595,336 | 10,281,486 | I |
Explanation of responses
- F1Each American Depositary Share ("ADS") is immediately convertible into three ordinary shares for no consideration and has no expiration date.
- F2The securities were sold by Cream Capital Limited ("CCL") and Mr. Griffiths personally. Mr Griffiths is a director and the controlling shareholder of CCL. Mr. Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein.